Publibee

Easy way to search PubMed and discuss articles. Because #PeerReview is not enough. Inspired by game-changers #Pubpeer #PubMedCommons.

[Publibee @Publibee_tweets]

After 2 years, Publibee had to stop its activities.Thanks everyone for this amazing ride !
Let’s continue to promote #postpublicationpeerreview

[Publibee @Publibee_tweets]

@stdebove On a créé une plateforme qui permet d’effectuer ses recherches sur PubMed et de discuter les articles directement dans le moteur de recherche. Le site s’appelle Publibee et vous pouvez le tester ici: https://t.co/UnAXgUBBme
On vient de se lancer!
#PostPublicationPeerReview

[Publibee @Publibee_tweets]

Excellent article on post-publication peer review by ⁦@ellis2013nz⁩
We work hard to make this vision become the new standard. https://t.co/gPQoKCFLZQ

[Publibee @Publibee_tweets]

Researchers can sometimes see what journals are missing. More post-publication peer review is needed. https://t.co/gy0EmiQEst

[Publibee @Publibee_tweets]

Thank you @TheLancet for retracting this article. It seems to be the right decision.
This is a perfect example of why Post-Publication peer review is needed (@PubPeer) and why we need to foster more discussion among scientists on articles.#PPPR

[The Lancet @TheLancet]

Today, three of the authors have retracted "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis" Read the Retraction notice and statement from The Lancet https://t.co/pPNCJ3nO8n

[Publibee @Publibee_tweets]

We launched Publibee officially on May 17th. We are a young platform continually adapting to the feedback of our users.
So, if you want to see things happen on the upcoming versions, please let us know in the chat!

[Publibee @Publibee_tweets]

Publibee is officially live!
- Search PubMed the way you always have.
- Benefit from an intuitive and easy to use interface
- Pin articles you like to resume your search anytime, anywhere
- Discuss articles online #PPPR
You can test it on https://t.co/UnAXgUBBme !

[Publibee @Publibee_tweets]

COVID-19 is deeply impacting how we share and appraise science.
#preprint & #PostPublicationPeerReview are the future of scientific publishing, and you can be part of it. @Publibee_tweets

https://t.co/l9R6LfLH39

[Publibee @Publibee_tweets]

"We must reason critically (...), and critically appraise evidence in deciding how to treat patients, and use anecdotal observations only to generate hypotheses for trials that can be conducted with clinical equipoise."
https://t.co/smsWJ1WhNC

[Publibee @Publibee_tweets]

Another enlightening appraisal by @rbganatra about an article on thrombotic complications in critically ill ICU patients with COVID-19.

[Rahul Ganatra @rbganatra]

1/
What is the risk of macrovascular thrombosis among critically ill patients with #SARSCoV2 #COVID19? Let’s take a look at the data.

Here’s #HowIReadThisPaper on a @ThromboisRese1 case series examining this question:

Klok et al: https://t.co/Iug13PCSVw

(Thread)

[Stelios Serghiou @SteliosSerghiou]

Is high-dose chloroquine (CQ) better than low-dose CQ?

TL;DR: Still unclear

Article: https://t.co/FTJbjz4KAk

Comment deposited on Publibee: @Publibee_tweets

(Thread)

[Publibee @Publibee_tweets]

Quick but weak studies are NOT better than nothing. #COVID-19
"Small studies that build on basic science and preclinical research in early phases of drug development routinely generate signals of promise that are not confirmed in subsequent trials."
https://t.co/9P5QYNLhkZ

[Dr. Tara C. Smith @aetiology]

Thank you to @IDRoadrunner for spearheading this review of Twitter & infectious diseases, with myself, @IDstewardship & @idpharmd. https://t.co/oeQLenwceK

[Publibee @Publibee_tweets]

Thanks @SteliosSerghiou for this analysis. #PeerReview is not enough, #PPPR

[Stelios Serghiou @SteliosSerghiou]

How well can we predict COVID-19 diagnosis and outcomes?

Article: https://t.co/MkNvUO7MPe

Comment deposited on Publibee: @Publibee_tweets

(Thread)

[Publibee @Publibee_tweets]

@zachweinberg @MarkUp_app Hey @zachweinberg!
We are developing something exactly along these lines, with a different format.
We are still testing our beta, but Publibee should be available very soon.
Stay tuned!

[Charlie M. Wray, DO, MS @WrayCharles]

1/ Here by popular demand “How to Publish in Academics When Publishing Isn’t Your Thing”.

A #Tweetorial on the picking & publishing low-hanging fruit in academic medicine.

Further input always welcome. By no means complete. Hope it helps. Thread…

[Marc Lipsitch @mlipsitch]

Always relevant. Why Most Published Research Findings Are False https://t.co/uVr86RAzKU

[Publibee @Publibee_tweets]

Thank you @rbganatra for this great analysis! #PeerReview is not enough.

[Rahul Ganatra @rbganatra]

1/
Should we use #remdesivir (RDV) to treat #COVID19 #SARSCoV2? Let’s take a look at the data.

Here’s: #HowIReadThisPaper on the @NEJM case series of remdesivir for COVID19:

Grein et al: https://t.co/VICMrsCKSB

(Thread)

[Publibee @Publibee_tweets]

Thanks @Lupusreference for pointing out this mistake. #PeerReview is not enough.

[Cochrane @cochranecollab]

Health claims - fact checked! https://t.co/k0tazEFrxf ➡️ @iHealthFacts1 is a resource where the public can quickly & easily check the reliability of #HealthClaims circulated on social media - including #covid19 claims. 🙌 Supported by @CochraneIreland